cancer

FDA okays biosimilar for several cancersWhile FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.
First gene therapy for cancer approved: What health execs should knowThe first therapy based on gene transfer has been approved by the FDA. What’s next for healthcare executives?
Impact of aspirin in reducing preterm preeclampsiaA study looks at the efficacy of aspirin in reducing preterm preeclampsia. Plus: The CDC reports on antidepressant use in the United States. Also, a look at whether vaginal estrogen postmenopause increases the risk of heart disease and certain types of cancer.
Health plans explain genetic testing coverage decisions
Health plans explain genetic testing coverage decisionsToday there are nearly 67,000 genetic tests. With so many tests available, it can be difficult for MCOs to determine what to cover.
Medical marijuana update: Top 3 things health execs should knowHere’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
How to approach value in oncologyAn eye-opening study by Precision for Value assesses cancer value frameworks.
Precision Medicine: A New Role for Pharmacists
Precision Medicine: A New Role for PharmacistsThe biggest innovation in medicine in the last decade (and how to get in on it).
Ocular surface tumors require careful exam, consideration of best options
Ocular surface tumors require careful exam, consideration of best optionsAlthough surgery is still the gold standard for ocular surface tumors, consider the pros and cons of topical chemotherapy as appropriate.
New pathways to cancer therapyA novel oral formulation of itraconazole (SUBA-Itraconazole, HedgePath Pharmaceuticals) is providing dramatic benefit for patients with basal cell carcinoma nevus syndrome (BCCNS, also known as Gorlin syndrome) and with a favorable safety profile, according to a recent interim analysis of data collected in a phase IIb study.
Consider different iris lesion forms before final clinical diagnosis
Consider different iris lesion forms before final clinical diagnosisUse these pearls to better diagnose and treat iris lesions.